Literature DB >> 22840318

Clinical characteristics and outcome in patients with isolated sphenoid sinus aspergilloma.

Jae Hoon Jung1, Gye Song Cho, Yoo-Sam Chung, Bong-Jae Lee.   

Abstract

OBJECTIVE: Isolated sphenoid sinus aspergilloma (ISSA) is a rare disorder that is difficult to diagnose in a timely manner. These lesions can also extend to adjacent structures and thereby cause severe complications. ISSA patients with orbital complications typically have a poor prognosis even when surgical interventions have been successful. We here reviewed 30 ISSA cases with respect to clinical characteristics and treatment outcomes.
METHODS: A group of 30 patients diagnosed with ISSA between January 1990 and October 2010 were retrospectively reviewed in terms of clinical manifestations, endoscopic findings, radiologic imaging data, and treatment results. We also compared the clinical manifestations and treatment results between patients with and without orbital complications.
RESULTS: Old age (median, 55 years) and a female predominance (23 women in the study) were noted. The most commonly reported symptom was headache (80%) and the average duration of the symptoms before diagnosis was 8.1 months. On radiologic examination, including CT and MRI scans, 13 patients showed bony wall erosions and five patients demonstrated orbital complications including diplopia and visual loss. The appearance of a bony wall erosion on a CT scan and the acute onset of ISSA symptoms were found to be significant factors in the onset of orbital complications (P=0.003 in each case). Endoscopic sphenoidotomy was performed in all 30 cases. Most of the preoperative symptoms among the patients, including headache, facial pain, and postnasal drip, were improved after surgery. Among the five patients in the study group with orbital complications, diplopia was completely resolved after surgery in each case but there was no improvement in visual loss.
CONCLUSIONS: An early diagnosis of ISSA, although not easy, is important to prevent complications arising from extensions of these lesions beyond the sphenoid sinus. Our present study demonstrates that ISSA could be effectively treated with an endoscopic sphenoidotomy, and that timely intervention is needed in patients with a sinus bony wall to prevent irreversible complications such as visual loss.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22840318     DOI: 10.1016/j.anl.2012.07.008

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  6 in total

1.  Unusual coincidence of a pituitary adenoma and an aspergilloma of the sphenoid sinus.

Authors:  Hajrullalh Ahmeti; Katharina Balschun; Hubertus M Mehdorn; Andreas M Stark
Journal:  J Neurooncol       Date:  2014-07-10       Impact factor: 4.130

2.  Isolated Sphenoid Sinusitis: Anatomical Features for Choosing a Method of Treatment, a Case-Control Study.

Authors:  Sergei Karpishchenko; Olga Vereshchagina; Olga Stancheva; Tatiana Nagornykh; Alexander Krasichkov; Irina Serdiukova; Aleksandr Sinitca; Dmitry Kaplun
Journal:  Diagnostics (Basel)       Date:  2022-05-21

3.  Isolated sphenoid fungal sinusitis and coexisting intrasellar mass lesion presenting with headache as the sole symptom.

Authors:  Cem Burak Kalaycı; Halime Cevik
Journal:  Acta Radiol Short Rep       Date:  2014-09-04

4.  Skull base erosion and associated complications in sphenoid sinus fungal balls.

Authors:  Josh C Meier; George A Scangas; Aaron K Remenschneider; Peter Sadow; Kyle Chambers; Matt Dedmon; Derrick T Lin; Eric H Holbrook; Ralph Metson; Stacey T Gray
Journal:  Allergy Rhinol (Providence)       Date:  2016-01-01

5.  Surgical treatment of isolated sphenoid sinusitis - A case series and review of literature.

Authors:  Noémie Villemure-Poliquin; Sylvie Nadeau
Journal:  Int J Surg Case Rep       Date:  2021-01-02

6.  A Case of Invasive Sphenoid Sinus Aspergillosis Presenting as Oculomotor Nerve Palsy in a Healthy Patient.

Authors:  Takashi Fujimoto; Yoichi Morofuji; Takeshi Hiu; Koichi Yoshida; Koichi Izumikawa; Takeshi Watanabe; Takayuki Matsuo
Journal:  NMC Case Rep J       Date:  2021-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.